APPHON/ROHPPA hosted an Educational Session on

Blinatumomab Administration for Healthcare Professionals

11 September 2024

Presented by:

Dr. Tamara MacDonald, Tracy MacNeil and Christa McGuirk

Blinatumomab is standard of care for children with relapsed acute lymphoblastic leukemia (ALL) and in de novo pediatric ALL for those who cannot tolerate or are resistant to conventional chemotherapy.

Advanced centres will be able to provide blinatumomab starting in the fall.

This session provided information on how to prepare and administer the drug and any other information required.

Review the slides and video recording:

VIEW VIDEO RECORDING

Presentation Slides:

Part 1 - Dr. Tamara MacDonald: Brief review of blinatumomab and indications for use in pediatric oncology

Part 2 - Tracy MacNeil: Pharmacy planning and preparation process

Part 3 - Christa McGuirk: Blinatumomab administration

For comments or questions, contact us.